Anita Reddy
YOU?
Author Swipe
View article: Vasopressin Initiation Timing and In-Hospital Mortality in Septic Shock: An Observational Study of Large Public Databases
Vasopressin Initiation Timing and In-Hospital Mortality in Septic Shock: An Observational Study of Large Public Databases Open
IMPORTANCE: Vasopressin is used in one-third of patients with septic shock to augment hemodynamics and reduce overall catecholamine exposure. However, the optimal clinical context in which to initiate vasopressin is unknown. OBJECTIVES: To…
View article: Revisiting insulin-stimulated hydrogen peroxide dynamics reveals a cytosolic reductive shift in skeletal muscle
Revisiting insulin-stimulated hydrogen peroxide dynamics reveals a cytosolic reductive shift in skeletal muscle Open
View article: Peripheral Administration of Norepinephrine
Peripheral Administration of Norepinephrine Open
View article: Table S1 from First-in-Human Phase I Study of ABBV-838, an Antibody–Drug Conjugate Targeting SLAMF7/CS1 in Patients with Relapsed and Refractory Multiple Myeloma
Table S1 from First-in-Human Phase I Study of ABBV-838, an Antibody–Drug Conjugate Targeting SLAMF7/CS1 in Patients with Relapsed and Refractory Multiple Myeloma Open
Overall summary of treatment-emergent adverse events
View article: Figure S1 from First-in-Human Phase I Study of ABBV-838, an Antibody–Drug Conjugate Targeting SLAMF7/CS1 in Patients with Relapsed and Refractory Multiple Myeloma
Figure S1 from First-in-Human Phase I Study of ABBV-838, an Antibody–Drug Conjugate Targeting SLAMF7/CS1 in Patients with Relapsed and Refractory Multiple Myeloma Open
Study design schematic. N, number of patients in each dose group; PK/PD, pharmacokinetics/pharmacodynamics.
View article: Figure S1 from First-in-Human Phase I Study of ABBV-838, an Antibody–Drug Conjugate Targeting SLAMF7/CS1 in Patients with Relapsed and Refractory Multiple Myeloma
Figure S1 from First-in-Human Phase I Study of ABBV-838, an Antibody–Drug Conjugate Targeting SLAMF7/CS1 in Patients with Relapsed and Refractory Multiple Myeloma Open
Study design schematic. N, number of patients in each dose group; PK/PD, pharmacokinetics/pharmacodynamics.
View article: Data from First-in-Human Phase I Study of ABBV-838, an Antibody–Drug Conjugate Targeting SLAMF7/CS1 in Patients with Relapsed and Refractory Multiple Myeloma
Data from First-in-Human Phase I Study of ABBV-838, an Antibody–Drug Conjugate Targeting SLAMF7/CS1 in Patients with Relapsed and Refractory Multiple Myeloma Open
Purpose:ABBV-838 is an antibody–drug conjugate targeting a unique epitope of CD2 subset 1, a cell-surface glycoprotein expressed on multiple myeloma cells. This phase I/Ib first-in-human, dose-escalation study (trial registration ID: NCT02…
View article: Data from First-in-Human Phase I Study of ABBV-838, an Antibody–Drug Conjugate Targeting SLAMF7/CS1 in Patients with Relapsed and Refractory Multiple Myeloma
Data from First-in-Human Phase I Study of ABBV-838, an Antibody–Drug Conjugate Targeting SLAMF7/CS1 in Patients with Relapsed and Refractory Multiple Myeloma Open
Purpose:ABBV-838 is an antibody–drug conjugate targeting a unique epitope of CD2 subset 1, a cell-surface glycoprotein expressed on multiple myeloma cells. This phase I/Ib first-in-human, dose-escalation study (trial registration ID: NCT02…
View article: Table S1 from First-in-Human Phase I Study of ABBV-838, an Antibody–Drug Conjugate Targeting SLAMF7/CS1 in Patients with Relapsed and Refractory Multiple Myeloma
Table S1 from First-in-Human Phase I Study of ABBV-838, an Antibody–Drug Conjugate Targeting SLAMF7/CS1 in Patients with Relapsed and Refractory Multiple Myeloma Open
Overall summary of treatment-emergent adverse events
View article: Lactate regulates cell cycle by remodelling the anaphase promoting complex
Lactate regulates cell cycle by remodelling the anaphase promoting complex Open
View article: Monocarboxylate transporters facilitate succinate uptake into brown adipocytes
Monocarboxylate transporters facilitate succinate uptake into brown adipocytes Open
Uptake of circulating succinate by brown adipose tissue (BAT) and beige fat elevates whole body energy expenditure, counteracts obesity, and antagonizes systemic tissue inflammation in mice. The plasma membrane transporters that facilitate…
View article: Isolation of extracellular fluids reveals novel secreted bioactive proteins from muscle and fat tissues
Isolation of extracellular fluids reveals novel secreted bioactive proteins from muscle and fat tissues Open
View article: Architecture of the outbred brown fat proteome defines regulators of metabolic physiology
Architecture of the outbred brown fat proteome defines regulators of metabolic physiology Open
View article: Association of Arterial pH With Hemodynamic Response to Vasopressin in Patients With Septic Shock: An Observational Cohort Study
Association of Arterial pH With Hemodynamic Response to Vasopressin in Patients With Septic Shock: An Observational Cohort Study Open
OBJECTIVES: Vasopressin is reported to retain vasoconstrictive activity in the setting of acidemia, but preclinical models are inconsistent and studies have not evaluated the clinical effectiveness of vasopressin based on arterial pH. This…
View article: Glucose metabolism and pyruvate carboxylase enhance glutathione synthesis and restrict oxidative stress in pancreatic islets
Glucose metabolism and pyruvate carboxylase enhance glutathione synthesis and restrict oxidative stress in pancreatic islets Open
View article: UCP1 governs liver extracellular succinate and inflammatory pathogenesis
UCP1 governs liver extracellular succinate and inflammatory pathogenesis Open
View article: Reinfection Rates Among Patients Who Previously Tested Positive for Coronavirus Disease 2019: A Retrospective Cohort Study
Reinfection Rates Among Patients Who Previously Tested Positive for Coronavirus Disease 2019: A Retrospective Cohort Study Open
Background Protection afforded from prior disease among patients with coronavirus disease 2019 (COVID-19) infection is unknown. If infection provides substantial long-lasting immunity, it may be appropriate to reconsider vaccination distri…
View article: Reinfection Rates among Patients who Previously Tested Positive for COVID-19: a Retrospective Cohort Study
Reinfection Rates among Patients who Previously Tested Positive for COVID-19: a Retrospective Cohort Study Open
Objectives To evaluate reinfection rates and protective effectiveness of prior disease among patients with coronavirus disease 2019 (COVID-19) infection in the United States. Design Retrospective cohort study Setting One multi-hospital hea…
View article: Home testing for COVID-19: Benefits and limitations
Home testing for COVID-19: Benefits and limitations Open
The home test kits for detecting SARS-CoV-2 infection with Food and Drug Administration emergency use authorization primarily use either isothermal nucleic acid amplification or antigen detection, and each test has advantages and limitatio…
View article: Response
Response Open
View article: Safety of bedside placement of tunneled dialysis catheter in COVID-19 patients
Safety of bedside placement of tunneled dialysis catheter in COVID-19 patients Open
COVID-19 patients admitted to the ICU have high incidence of AKI requiring prolonged renal replacement therapy and often necessitate the placement of a tunneled dialysis catheter (TDC). We describe our experience with two cases of COVID-19…
View article: Hemodynamic Response to Vasopressin Dosage of 0.03 Units/Min vs. 0.04 Units/Min in Patients With Septic Shock
Hemodynamic Response to Vasopressin Dosage of 0.03 Units/Min vs. 0.04 Units/Min in Patients With Septic Shock Open
Background: Arginine vasopressin (AVP) is suggested as an adjunct to norepinephrine in patients with septic shock. Guidelines recommend an AVP dosage up to 0.03 units/min, but 0.04 units/min is commonly used in practice based on initial st…
View article: pH-Gated Succinate Secretion Regulates Muscle Remodeling in Response to Exercise
pH-Gated Succinate Secretion Regulates Muscle Remodeling in Response to Exercise Open
View article: Interhospital transport of patients with COVID-19: Cleveland Clinic approach
Interhospital transport of patients with COVID-19: Cleveland Clinic approach Open
Hospital-to-hospital transportation of patients in the COVID-19 era presents unique challenges to ensuring the safety of both patients and health care providers. Crucial factors to address include having adequate supplies of protective equ…
View article: Operationalizing COVID-19 testing: Who, what, when, where, why, and how
Operationalizing COVID-19 testing: Who, what, when, where, why, and how Open
The authors review the rationale behind and approaches to testing for COVID-19, the quality of currently available tests, the role of data analytics in strategizing testing, and using the electronic medical record and other programs design…
View article: Association Between Compliance With the Sepsis Quality Measure (SEP-1) and Hospital Readmission
Association Between Compliance With the Sepsis Quality Measure (SEP-1) and Hospital Readmission Open
View article: A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging
A Quantitative Tissue-Specific Landscape of Protein Redox Regulation during Aging Open
View article: Bispectral Index for Titrating Sedation in ARDS Patients During Neuromuscular Blockade
Bispectral Index for Titrating Sedation in ARDS Patients During Neuromuscular Blockade Open
Titration based on bispectral index did not result in a significant difference in sedation or analgesia exposure, or clinical outcomes, from that achieved with traditional sedation monitoring in patients with ARDS who were receiving a neur…
View article: Sulforaphane enriched transcriptome of lung mitochondrial energy metabolism and provided pulmonary injury protection via Nrf2 in mice
Sulforaphane enriched transcriptome of lung mitochondrial energy metabolism and provided pulmonary injury protection via Nrf2 in mice Open
View article: Joblessness and Lost Earnings after Acute Respiratory Distress Syndrome in a 1-Year National Multicenter Study
Joblessness and Lost Earnings after Acute Respiratory Distress Syndrome in a 1-Year National Multicenter Study Open
At 12 months after ARDS, nearly one-half of previously employed survivors were jobless. Post-ARDS joblessness is associated with readily identifiable patient and hospital variables and accompanied by substantial lost earnings and a shift t…